Drug Delivery Current Events | Drug Delivery News | 5
|
| Page
5 of
44 |
865 Results |
|
|
|
Sort By:
Page Views | Date |
Is inhaled insulin delivery still a possibility? Why has it been a commercial failure?
The commercial failure of Exubera® (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market. view more (2009-09-24)
CT colonography even safer than previously reported, says study
The safety profile for CT colonography (CTC) is extremely favorable, particularly for the purposes of screening patients with no symptoms and when distending the colon using an automated carbon dioxide technique, a finding that goes against the higher complication rates for CTC reported by other groups, according to a new study. view more (2006-05-02)
Better training needed to reduce emergency caesareans
Many emergency caesareans could be prevented by the attendance of a more skilled obstetrician. view more (2006-09-22)
UCSB researchers show how to make polymeric micro- and nanoparticles
Researchers in the College of Engineering at UC Santa Barbara have discovered how to make polymeric micro- and nanoparticles in a wide variety of different shapes and sizes using commonly-available lab chemicals and equipment. view more (2007-07-10)
Oxford Biomedica Obtains Further Fundamental Patent For Lentiviral Gene Therapy Technology
Oxford BioMedica plc announced today that it has received allowance from the US Patent Office for a further patent covering its proprietary LentiVector technology. This additional patent compliments the US patent 6,312,682 issued in November 2001 and both include broad composition of matter claims and methods of production claims for lentiviral... view more... (2003-08-13)
Maternal deaths following cesarean delivery can be reduced
Maternal death rates have remained constant in the United States for many decades. Are there any improvements in health care that could reduce these rates further? view more (2008-08-04)
Promise of nanodiamonds for safer gene therapy
Gene therapy holds promise in the treatment of a myriad of diseases, including cancer, heart disease and diabetes, among many others. view more (2009-09-01)
A drug-dispensing contact lens
Taking eye drops multiple times a day can be difficult for patients to do, and because of blinking and tearing, as little as 1 to 7 percent of the dose is actually absorbed by the eye. view more (2009-07-22)
Founder's Lecture will Recognise the Success of Colloid Chemist
Professor Terence Cosgrove, University of Bristol, UK, will deliver the Founder's Lecture 'Chains and Bondage' at the Society of Chemical Industry (SCI) Headquarters, London on 21 April 2004. The Founder's Lecture is awarded to figures of distinction in the colloid or surface chemistry fields. A Professor of Physical Chemistry, Terence Cosgrove is... view more... (2004-04-19)
Pregnancy research leads to progress on premature delivery
The University of Rochester has filed a patent on several ideas to help prevent early labor and the premature delivery of low-birth-weight babies. view more (2006-03-23)
Pregnancy complications are a stress test for future maternal health and pregnancies
Predicting whether pregnancy complications affect long-term maternal health as well as future pregnancies is at the heart of two studies conducted by researchers in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine. view more (2009-07-20)
New study shows that therapeutic gene expression can be sustainable for 1 year
Researchers at the Board of Governors Gene Therapeutics Research Institute at Cedars-Sinai Medical Center have shown for the first time that it is possible to sustain therapeutic gene expression in the central nervous system for up to a year, even in the presence of an anti-viral immune response mechanism that is normally present in humans. view more (2007-10-26)
Penn study shows lower Cesarean rates associated with preventive labor induction
At a time when national rates of cesarean delivery have climbed above 30%, a four-year study of patients receiving an alternative method of obstetric care experienced a significantly lower rate of cesarean births, according to a study published in the current issue of the Annals of Family Medicine. view more (2007-07-31)
Harnessing Microbes to Kill Cancer
An ingenious new way to attack cancer tumours is being developed by medical researchers from Nottingham as part of an EU consortium, the Society for General Microbiology's Spring Meeting in Edinburgh heard today, Tuesday 8 April 2003. The problem with powerful anti-cancer drugs is that they kill healthy cells too, and concentrations needed to wipe... view more... (2003-04-02)
Penn team uses self-assembly to make molecule-sized particles with patches of charge
Physicists, chemists and engineers at the University of Pennsylvania have demonstrated a novel method for the controlled formation of patchy particles, using charged, self-assembling molecules that may one day serve as drug-delivery vehicles to combat disease and perhaps be used in small batteries that store and release charge. view more (2009-10-21)
Possible biological explanation for C-Section-linked allergies and asthma found
Scientists believe they may have identified a biological explanation for the link between cesarean-section delivery and risk of allergy and asthma in childhood. view more (2008-05-21)
Standing up to paraplegia with gene therapy
Elena Rugarli and colleagues from the National Neurological Institute in Milan have used gene therapy to save sensory and skeletal muscle nerve fibers from degeneration in mice with hereditary spastic paraplegia (HSP). view more (2005-12-16)
Intravenous delivery of clot-busting drug still best intervention for ischemic stroke
Intravenous delivery of an approved clot-busting drug remains the most beneficial proven intervention for ischemic stroke, according to updated American Heart Association/American Stroke Association guidelines published in Stroke: Journal of the American Heart Association. view more (2007-04-16)
Anti-fungal drug stops blood vessel growth
Researchers at Johns Hopkins have discovered to their surprise that a drug commonly used to treat toenail fungus can also block angiogenesis, the growth of new blood vessels commonly seen in cancers. view more (2007-04-30)
Using virtual learning environments: is the training right?
In the past it was always the case that students were expected to either know, or learn for themselves, how to take notes in lectures, participate in seminars, and so on. Within a modern context, we now recognise that students need guidance and training if they are to make the most of these learning environments. That's the result of research... view more... (2001-06-25)
|
|
| Page
5 of
44 |
865 Results |
|
|
|
Sort By:
Page Views | Date |
|
